Volume 62, Issue 50 e202309160
Minireview

Nanomedicine-Enabled Chemical Regulation of Reactive X Species for Versatile Disease Treatments

Xinyue Dai

Xinyue Dai

Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444 China

Search for more papers by this author
Yujie Xie

Corresponding Author

Yujie Xie

Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444 China

School of Medicine, Shanghai University, Shanghai, 200444 China

Search for more papers by this author
Wei Feng

Corresponding Author

Wei Feng

Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444 China

Search for more papers by this author
Yu Chen

Corresponding Author

Yu Chen

Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444 China

School of Medicine, Shanghai University, Shanghai, 200444 China

Search for more papers by this author
First published: 31 August 2023
Citations: 13

Graphical Abstract

This minireview provides a summary of the chemistry and mechanisms governing reactive species (RXS) based nanomedicine, focusing on metabolic regulation, the role of nanomedicine in RXS generation and elimination. The challenges and future prospects associated with RXS for disease treatments are further discussed, aiming to facilitate the clinical translation of RXS-based nanomedicine and open new avenues for improved therapeutic interventions.

Abstract

Reactive X species (RXS), encompassing elements such as O, N, C, S, Se, Cl, Br, I, and H, play vital roles in cell biology and physiological function, impacting cellular signal transduction, metabolic regulation, and disease processes. The redox unbalance of RXS is firmly implicated in an assortment of physiological and pathological disorders, including cancer, diabetes, cardiovascular disease, and neurodegenerative diseases. However, the intricate nature and multifactorial dependence of RXS pose challenges in comprehending and precisely modulating their biological behavior. Nanomaterials with distinct characteristics and biofunctions offer promising avenues for generating or scavenging RXS to maintain redox homeostasis and advance disease therapy. This minireview provides a tutorial summary of the relevant chemistry and specific mechanisms governing different RXS, focusing on cellular metabolic regulation, stress responses, and the role of nanomedicine in RXS generation and elimination. The challenges associated with chemically regulating RXS for diverse disease treatments are further discussed along with the future prospects, aiming to facilitate the clinical translation of RXS-based nanomedicine and open new avenues for improved therapeutic interventions.

Conflict of interest

The authors declare no conflict of interest.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.